Pfizer files for US approval for Omicron booster for kids / Photo: JACK GUEZ - AFP/File
-
Samsung logs record quarterly profits despite investor AI jitters
-
Microsoft beats expectations fueled by Azure cloud business
-
Shares in Google owner Alphabet plummet on profit miss, ad slowdown
-
Shares in Google owner Alphabet sink on profit miss, ad slowdown
-
US Fed holds interest rates steady despite 'too high' inflation
-
Pioneering US labor leader Dolores Huerta dies at 96
-
Airbus aims for record deliveries despite disappointing quarter
-
US Fed holds interest rates steady despite surging inflation
-
Real Madrid, La Liga apology over Mbappe shows power of Chinese market
-
US labor leader Dolores Huerta dead: family
-
'Cruise for life' strands passengers in Cambodia as operator goes bust
-
French firm Safran helps build aircraft wings of the future in UK factory
-
Canada hikes rates to contain oil price surge caused by Iran war
-
World Bank warns of worsening food insecurity as commodity prices soar
-
Nintendo producer 'all nervous' as Zelda classic remake hits shelves
-
Billionaire Ambani's Jio soars in market debut after India's biggest IPO
-
Three killed by storm in southern India
-
AI chip giant SK hynix posts seven-fold surge in quarterly operating profit
-
Two hundred 'Cruise for life' passengers stranded in Cambodia
-
S.African activists push back on data centre rush
-
Billionaire Ambani's Jio jumps 21% in market debut after record India IPO
Pfizer files for US approval for Omicron booster for kids
Pfizer and BioNTech have asked United States health officials to authorize their Omicron-targeting Covid booster vaccine for children aged 5 to 11, the companies said Monday.
The companies sent a request for emergency authorization for a 10-microgram dose to the US Food and Drug Administration.
This new generation of anti-Covid vaccines targets both the original strain of coronavirus and the BA.4 and BA.5 lineages, the subvariants of Omicron that are causing more than 90% of infections in the United States.
If the FDA authorizes the vaccine, the shot will still need another green light from the Centers for Disease Control and Prevention, the country's main federal health agency, before the first injections can be administered to children.
In the coming days, Pfizer and BioNTech will also file for authorization with the European Medicines Agency, they said.
Even though children have been less affected by Covid-19 than adults, several hundred children aged 5 to 18 have died in the United States since the start of the pandemic, according to CDC figures.
In September, the CDC cleared Omicron-specific versions of the Pfizer-BioNTech vaccine for people over the age of 12 and of the Moderna vaccine for those over 18, paving the way for a booster campaign.
T.Morelli--CPN
